GLF
UTHR icon

Groupe la Francaise’s United Therapeutics UTHR Stock Holding History

Groupe la Francaise’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.21K Sell
17
-1
-6% -$563 ﹤0.01% 465
2026
Q1 		$10.7K Buy
+18
New +$8.96K ﹤0.01% 429
2025
Q1 		– Sell
-66
Closed -$23.6K – 464
2024
Q4 		$23.6K Buy
+66
New +$24.3K ﹤0.01% 315

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Groupe la Francaise's UTHR Position: Q2 2026 in Review

Groupe la Francaise reduced its United Therapeutics (UTHR) stake by 5.6% in Q2 2026, selling an estimated $563 and leaving 17 shares worth $9.21K. The position accounts for ﹤0.01% of the portfolio, ranked #465.

Groupe la Francaise first reported a position in UTHR in Q4 2024 and has held it in 3 quarters since. The position peaked at $23.6K in Q4 2024. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Groupe la Francaise held 17 shares of United Therapeutics worth $9.21K as of Q2 2026.
  • Groupe la Francaise sold 1 United Therapeutics share in Q2 2026, an estimated $563.
  • United Therapeutics made up ﹤0.01% of Groupe la Francaise's portfolio in Q2 2026, its #465 holding.
  • Groupe la Francaise first reported a position in United Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Groupe la Francaise's United Therapeutics position peaked at $23.6K in Q4 2024.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.